NDC 70720-101

Varubi

Rolapitant

Varubi is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Tersera Therapeutics Llc. The primary component is Rolapitant Hydrochloride.

Product ID70720-101_5de36f8a-cbc2-4884-8fcf-e9302d41c2f8
NDC70720-101
Product TypeHuman Prescription Drug
Proprietary NameVarubi
Generic NameRolapitant
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-10-07
Marketing CategoryNDA / NDA
Application NumberNDA206500
Labeler NameTerSera Therapeutics LLC
Substance NameROLAPITANT HYDROCHLORIDE
Active Ingredient Strength90 mg/1
Pharm ClassesNeurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 70720-101-02

2 TABLET in 1 BLISTER PACK (70720-101-02)
Marketing Start Date2019-08-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70720-101-02 [70720010102]

Varubi TABLET
Marketing CategoryNDA
Application NumberNDA206500
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-08-06

Drug Details

Active Ingredients

IngredientStrength
ROLAPITANT HYDROCHLORIDE90 mg/1

OpenFDA Data

SPL SET ID:a52896cd-4a98-49b8-82db-bf1985a64d97
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1665503
  • 1673373
  • Pharmacological Class

    • Neurokinin 1 Antagonists [MoA]
    • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Breast Cancer Resistance Protein Inhibitors [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Neurokinin 1 Antagonists [MoA]
    • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Breast Cancer Resistance Protein Inhibitors [MoA]
    • P-Glycoprotein Inhibitors [MoA]

    NDC Crossover Matching brand name "Varubi" or generic name "Rolapitant"

    NDCBrand NameGeneric Name
    69656-101Varubirolapitant
    69656-102Varubirolapitant
    70720-101Varubirolapitant

    Trademark Results [Varubi]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VARUBI
    VARUBI
    86591285 4893721 Live/Registered
    Tesaro, Inc.
    2015-04-08

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.